Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F21BV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,493
Award facts
- Contract value 100% obligated
- $24,493.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,493.22 to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120 count units). This firm fixed-price, non-set-aside contract was awarded on January 22, 2026, with an ultimate completion date of February 12, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in the federal medical supply chain. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Lynparza, an oncology medication, represents one of many specialized pharmaceuticals delivered under this IDC arrangement. The competitively awarded contract demonstrates AmerisourceBergen's established capability to meet federal procurement requirements for essential pharmaceutical commodities supporting defense health operations.
Quick answers
Who was awarded contract SPE2DR26F21BV?
SPE2DR26F21BV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F21BV worth?
The government has obligated $24,493 on SPE2DR26F21BV.
Is contract SPE2DR26F21BV an order under another contract?
Yes. SPE2DR26F21BV is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21BV competed?
The extent of competition for SPE2DR26F21BV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award